Physician profile
Ann C Still
NPI 1811977135
$821.68
in general payments reported to CMS, 2019-2025
16 companies · $46.09 in 2025
The $46.09 reported for 2025 was less than what a typical Addiction Medicine (Anesthesiology) provider received nationally (typical 2025 total: $133).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $71.27 · 2022: $82.71 · 2023: $47.50 · 2024: $78.14 · 2025: $46.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $176.89 | 2019 | |
| Boston Scientific Corporation | $164.75 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Indivior INC. | $158.14 | 2019-2025 | Sublocade |
| Daiichi Sankyo INC. | $64.69 | 2019 | |
| Bioventus LLC | $43.60 | 2019 | |
| Mdd US Operations, LLC | $34.73 | 2019 | |
| Biodelivery Sciences International, INC. | $28.56 | 2019-2020 | |
| Pfizer INC. | $26.21 | 2019 | |
| Braeburn INC. | $20.83 | 2024 | Brixadi |
| Amgen INC. | $18.21 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.35 | 2020 | |
| Abbvie INC. | $14.82 | 2022 | |
| Orexo US, INC. | $14.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.90 | 2019 | |
| Zyla Life Sciences, INC. | $13.17 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Still listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.